Cited by 108Microtubule and mitosis dynamicsCell death mechanisms and regulationCancer-related Molecular Pathways

Mitotic catastrophe and cancer drug resistance: A link that must to be broken

Denisenko, Tatiana V., Sorokina, Irina V., Gogvadze, Vladimir, Zhivotovsky, Boris·2016·Drug Resistance Updates

Abstract

An increased tendency of genomic alterations during the life cycle of cells leads to genomic instability, which is a major driving force for tumorigenesis. A considerable fraction of tumor cells are tetraploid or aneuploid, which renders them intrinsically susceptible to mitotic aberrations, and hence, are particularly sensitive to the induction of mitotic catastrophe. Resistance to cell death is also closely linked to genomic instability, as it enables malignant cells to expand even in a stressful environment. Currently it is known that cells can die via multiple mechanisms. Mitotic catastrophe represents a step preceding apoptosis or necrosis, depending on the expression and/or proper function of several proteins. Mitotic catastrophe was proposed to be an onco-suppressive mechanism and the evasion of mitotic catastrophe constitutes one of the gateways to cancer development. Thus, stimulation of mitotic catastrophe appears to be a promising strategy in cancer treatment. Indeed, several chemotherapeutic drugs are currently used at concentrations that induce apoptosis irrespective of the cell cycle phase, yet are very efficient at triggering mitotic catastrophe at lower doses, significantly limiting side effects. In the present review we summarize current data concerning the role of mitotic catastrophe in cancer drug resistance and discuss novel strategies to break this link.

Integrity signals

Registry

Crossref · 10.1016/j.drup.2015.11.002

Cites

126 of 126 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Denisenko, T. V., Sorokina, I. V., Gogvadze, V., & Zhivotovsky, B.
Affiliations
Lomonosov Moscow State University (RU)
Corresponding author
Zhivotovsky, Boris
Venue
Drug Resistance Updates
Publisher
Elsevier BV
Published
2016-01
Volume
24
Pages
1-12
ISSN
1368-7646 (ISSN-L)
OpenAlex
W2176757944
Cited by
108
References
126
Citations by year
2026: 6 · 2025: 6 · 2024: 14 · 2023: 12 · 2022: 13 · 2021: 13 · 2020: 9 · 2019: 6 · 2018: 11 · 2017: 11 · 2016: 7
FWCI
0.97
Type
journal article
Language
en
Open access
closed
Locations
  • Drug Resistance Updates (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Russian Foundation for Basic Research
  • Russian Science Foundation
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Microtubule and mitosis dynamics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
  • Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
Keywords
mitotic catastrophe, chemoresistance, genomic instability, aneuploidy, tetraploidy, apoptosis, necrosis, oncosuppression, cancer cell death, chemotherapeutic drugs
MeSH terms
Antineoplastic Agents, Cell Cycle, DNA Damage, Humans, Mutation, Neoplasms, Apoptosis, Drug Resistance, Neoplasm, Genomic Instability

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review